Search Results - Toshio Imai

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Alteration in molecular properties during establishment and passaging of endometrial carcinoma patient-derived xenografts by Toshio Imai, Hiroshi Yoshida, Yukino Machida, Mizuki Kuramochi, Hitoshi Ichikawa, Takashi Kubo, Mami Takahashi, Tomoyasu Kato

    Published in Scientific Reports (2023-05-01)
    Get full text
    Article


  2. 2

    The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival by Yoshikazu Kuboi, Yukiko Kuroda, Masayoshi Ohkuro, Sotaro Motoi, Yoshiya Tomimori, Hisataka Yasuda, Nobuyuki Yasuda, Toshio Imai, Koichi Matsuo

    Published in JBMR Plus (2022-10-01)
    Get full text
    Article


  3. 3

    Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis by Yoshikazu Kuboi, Yuta Suzuki, Sotaro Motoi, Chiyuki Matsui, Naoki Toritsuka, Tomoya Nakatani, Kazuhiro Tahara, Yoshinori Takahashi, Yoko Ida, Ayaka Tomimatsu, Motohiro Soejima, Toshio Imai

    Published in Molecular Therapy: Nucleic Acids (2023-03-01)
    Get full text
    Article


  4. 4

    Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model by Takumi Hasegawa, Akira Utsunomiya, Takenao Chino, Hiroshi Kasamatsu, Tomomi Shimizu, Takashi Matsushita, Takashi Obara, Naoto Ishii, Hideaki Ogasawara, Wataru Ikeda, Toshio Imai, Noritaka Oyama, Minoru Hasegawa

    Published in Arthritis Research & Therapy (2024-05-01)
    Get full text
    Article


  5. 5

    Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice by Satoshi Mizutani, Junko Nishio, Kanoh Kondo, Kaori Motomura, Zento Yamada, Shotaro Masuoka, Soichi Yamada, Sei Muraoka, Naoto Ishii, Yoshikazu Kuboi, Sho Sendo, Tetuo Mikami, Toshio Imai, Toshihiro Nanki

    Published in Pharmaceuticals (2021-05-01)
    Get full text
    Article


  6. 6

    A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis by Atsushi Tanaka, Masanori Abe, Tadashi Namisaki, Shinji Shimoda, Mikio Zeniya, Akio Ido, Hitoshi Yoshiji, Hiromasa Ohira, Kenichi Harada, Yuko Kakuda, Atsushi Umeda, Yuki Kamiya, Yukari Higashine, Seiichiro Hojo, Toshio Imai, Tetsu Kawano, Yasuni Nakanuma, Hirohito Tsubouchi

    Published in Journal of Translational Autoimmunity (2025-06-01)
    Get full text
    Article


Search Tools: